Development
Intuitive Surgical, Inc.
ISRG
$557.08
-$0.98-0.18%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 14.49% | 11.98% | 11.75% | 8.89% | 8.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.49% | 11.98% | 11.75% | 8.89% | 8.97% |
| Cost of Revenue | 18.18% | 16.01% | 16.75% | 15.83% | 15.68% |
| Gross Profit | 12.71% | 10.06% | 9.41% | 5.75% | 6.00% |
| SG&A Expenses | 14.73% | 11.38% | 15.46% | 17.60% | 16.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.03% | 15.03% | 17.56% | 18.39% | 18.72% |
| Operating Income | 10.07% | 3.76% | -2.85% | -12.56% | -11.85% |
| Income Before Tax | 21.91% | 10.29% | -0.35% | -11.81% | -15.00% |
| Income Tax Expenses | -46.04% | 6.71% | -0.52% | 59.91% | 61.78% |
| Earnings from Continuing Operations | 35.18% | 11.00% | -0.32% | -19.64% | -22.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 12.67% | -114.52% | -26.09% | -29.35% | 5.96% |
| Net Income | 35.98% | 10.07% | -0.66% | -20.19% | -22.43% |
| EBIT | 10.07% | 3.76% | -2.85% | -12.56% | -11.85% |
| EBITDA | 10.72% | 5.89% | -0.21% | -8.65% | -7.96% |
| EPS Basic | 37.68% | 12.06% | 1.01% | -19.41% | -22.38% |
| Normalized Basic EPS | 18.47% | 15.57% | 5.30% | -7.45% | -10.36% |
| EPS Diluted | 37.42% | 12.35% | 1.72% | -18.54% | -21.51% |
| Normalized Diluted EPS | 18.47% | 15.91% | 6.07% | -6.53% | -9.51% |
| Average Basic Shares Outstanding | -1.27% | -1.78% | -1.63% | -0.96% | -0.09% |
| Average Diluted Shares Outstanding | -1.27% | -2.06% | -2.32% | -1.94% | -1.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |